Real launches with dates and figures you can check against public sources.
INNORINI PTE. LTD. (UEN 202015523Z) publishes case studies only where dates and figures can be checked against public sources. The first covers Nasodine: from promotion to Singapore healthcare professionals in November 2024 to an exclusive licence for Singapore, Malaysia, Brunei and Mauritius in August 2025, with Guardian retail distribution and the Singapore launch of Nasodine Throat Spray in January 2026.
From doctor sampling in November 2024 to exclusive licensee for Singapore, Malaysia, Brunei and Mauritius, Guardian retail and a second product launch.
Read the case study →
Innolax Essential and Innolax Detox began as Rishi Nandiraju’s iDP final-year project and won the Most Innovative Project Award at the NUS iDP Project Showcase 2024.
About the award →